Cargando…

Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making

Background: Brexanolone (BRX) injection was approved by the United States Food and Drug Administration in 2019 for the treatment of adults with postpartum depression (PPD) based on two Phase 3 clinical trials. Materials and Methods: Data from the three trials were combined. PPD-specific 17-item Hami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerbasi, Margaret E., Meltzer-Brody, Samantha, Acaster, Sarah, Fridman, Moshe, Bonthapally, Vijayveer, Hodgkins, Paul, Kanes, Stephen J., Eldar-Lissai, Adi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957380/ https://www.ncbi.nlm.nih.gov/pubmed/33181049 http://dx.doi.org/10.1089/jwh.2020.8483

Ejemplares similares

Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression
por: Gerbasi, Margaret E., et al.
Publicado: (2020)

Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States
por: Eldar-Lissai, Adi, et al.
Publicado: (2020)

Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression
por: Cooper, Miranda C., et al.
Publicado: (2019)

Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
por: Kanes, Stephen J., et al.
Publicado: (2017)

Efficacy of brexanolone in postpartum depression
por: Rodríguez Mercado, C. M.
Publicado: (2023)

Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
por: Meltzer-Brody, Samantha, et al.
Publicado: (2020)

Epidemiology of Pediatric Essential Tremor in the United States: A Systematic Literature Review from 2010 to 2020
por: Gerbasi, Margaret E., et al.
Publicado: (2022)

Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
por: Shukla, Ajay Kumar, et al.
Publicado: (2021)

Brexanolone as adjunctive therapy in super‐refractory status epilepticus
por: Rosenthal, Eric S., et al.
Publicado: (2017)

Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways
por: Balan, Irina, et al.
Publicado: (2023)

Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
por: Garafola, Svetlana, et al.
Publicado: (2023)

Treating Postpartum Depression: What Do We Know about Brexanolone?
por: Ali, Muneeza, et al.
Publicado: (2021)

Essential tremor patients experience significant burden beyond tremor: A systematic literature review
por: Gerbasi, Margaret E., et al.
Publicado: (2022)

Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?
por: Faden, Justin, et al.
Publicado: (2020)

Patient-reported perceptions of brexanolone in the treatment of postpartum depression: A qualitative analysis
por: Salwan, Aaron, et al.
Publicado: (2023)

Brexanolone, a GABA(A) Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review
por: Edinoff, Amber N., et al.
Publicado: (2021)

New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum
por: Meltzer-Brody, Samantha
Publicado: (2011)

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
por: Reddy, Doodipala Samba, et al.
Publicado: (2023)

Measuring hemophilia caregiver burden: validation of the Hemophilia Caregiver Impact measure
por: Schwartz, Carolyn E., et al.
Publicado: (2017)

A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
por: Hux, Margaret, et al.
Publicado: (2016)

Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial
por: Deligiannidis, Kristina M., et al.
Publicado: (2021)

The impact of extended half-life versus conventional factor product on hemophilia caregiver burden
por: Schwartz, Carolyn E., et al.
Publicado: (2018)

Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience
por: Lüscher, Bernhard, et al.
Publicado: (2019)

Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression
por: Rudzinskas, Sarah A., et al.
Publicado: (2023)

App-Based Ecological Momentary Assessment to Enhance Clinical Care for Postpartum Depression: Pilot Acceptability Study
por: Krohn, Holly, et al.
Publicado: (2022)

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013)

Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose
por: Wald, Jeffrey, et al.
Publicado: (2022)

Cross-continental collaboration for understanding postpartum major depression with psychotic features
por: Kimmel, Mary, et al.
Publicado: (2022)

Health-related quality of life in prisoners with attention-deficit hyperactivity disorder and head injury
por: Young, Susan, et al.
Publicado: (2018)

The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system
por: Young, Susan, et al.
Publicado: (2018)

Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial
por: Spelke, M. Bridget, et al.
Publicado: (2022)

PPD ACT: an app-based genetic study of postpartum depression
por: Guintivano, Jerry, et al.
Publicado: (2018)

The Childbirth Experience Survey (CBEX) and COVID-19: the ABCs of vaccine hesitancy in postpartum people
por: Saeb, Samia, et al.
Publicado: (2022)

Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance
por: Guintivano, Jerry, et al.
Publicado: (2022)

Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns
por: Hodgkins, Paul, et al.
Publicado: (2013)

Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective
por: Setyawan, Juliana, et al.
Publicado: (2014)

Making friends on the fly advances in ad hoc teamwork
por: Barrett, Samuel
Publicado: (2015)

Optimizing the treatment of mood disorders in the perinatal period
por: Meltzer-Brody, Samantha, et al.
Publicado: (2015)

Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape
por: Mehta, Divya, et al.
Publicado: (2021)

An EEG–MEG Dissociation between Online Syntactic Comprehension and Post Hoc Reanalysis
por: Meltzer, Jed A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ba2su2qfc3aqukjao9g80nfs1j